Scientists Design Molecule to Slow SARS-Cov-2 Infection
A team of scientists have designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be ...
Tag: Antivirals
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats ENA Respiratory has been awarded ...
Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent ...
Texas Biomed Tapped for National ‘Dream Team’ Developing Antivirals Against Biothreats
As the coronavirus waves keep coming and cases are on the rise once again, the National Institutes of Health (NIH) ...
Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against ...
Building Better Antivirals for the Next Pandemic
New research shows for the first time why the antiviral drug remdesivir works against some viruses but not others—a finding ...
Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray
COVID-19 is both contracted and transmitted by inhalation of droplets or aerosols containing the SARS-CoV-2 virus, and the nose is ...
The Future of Malaria Research Symposium
The Johns Hopkins Malaria Research Institute will host the 7th Future of Malaria Research Symposium on November 12, prior to the American Society ...
New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells
Scientists at Washington University School of Medicine in St. Louis are collaborating with the NIH researchers to test the MM3122 ...
Breakthrough Results for Dengue Antiviral: Janssen Compound Shows Promise Against All Serotypes
Named one of the top ten threats in 2019 by the World Health Organization, dengue is critically important to global health ...
Navrogen Enters CRADA with USAMRIID to Test Small Molecule NK Cell Activators Against SARS-COV-2 Infection
USAMRIID will test Navrogen's NAV-201 small molecule against SARS-COV-2 infected human epithelial cells in vitro and in in vivo rodent studies Navrogen, Inc. has ...
NIAID to Create New Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking applications to establish the Antiviral Drug Discovery (AViDD) program ...
University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that ...
SARS-CoV-2 Stem-Loop II Motif: Potential Target for Anti-viral Drugs
While the world awaits broad distribution of COVID-19 vaccines, researchers at Ohio University just published highly significant and timely results ...
Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead
Last month, the Food and Drug Administration (FDA) gave its first full approval for a COVID-19 therapeutic to Gilead Sciences' ...
Targeting the Shell of the Ebola Virus for a Knock-Out with Antivirals
How can we battle these infectious agents such as Ebola virus disease (EVD) that reproduce by hijacking cells and reprogramming ...
FDA Approves First Ebola Therapeutic
The U.S. Food and Drug Administration this week approved Inmazeb, previously called REGN-EB3, a mixture of three monoclonal antibodies made ...
Stopping Lethal Lung Damage from Influenza: MG53 Protein Shows Promise in Animal Models
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a ...
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. ...
Remdesivir: Second Mechanism of Action Against SARS-CoV-2 Revealed in New Study
Researchers at the University of Alberta have discovered a novel, second mechanism of action by the antiviral drug remdesivir against ...
